Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FDA has questions about Merck's experimental chronic cough drug By: Philadelphia Business Journal via Business Journals January 24, 2022 at 12:13 PM EST The chronic cough drug was approved in Japan, where it will be marketed under the brand name Lyfnua. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
FDA has questions about Merck's experimental chronic cough drug By: Philadelphia Business Journal via Business Journals January 24, 2022 at 12:13 PM EST The chronic cough drug was approved in Japan, where it will be marketed under the brand name Lyfnua. Read More >>